PD-L1 expression and survival in patients with locally advanced cervical cancer treated with chemoradiotherapy

被引:0
|
作者
Enwere, E. [1 ]
Kornaga, E. [2 ]
Koulis, T. [3 ]
Dean, M. [2 ]
Phan, T. [3 ]
Ghatage, P. [4 ]
Magliocco, A. [5 ]
Lees-Miller, S. [6 ]
Doll, C. [3 ]
机构
[1] Tom Baker Canc Clin, Pathol & Lab Med, Translat Lab, Funct Tissue Imaging Unit, Calgary, AB, Canada
[2] Tom Baker Canc Clin, Pathol & Lab Med, Translat Lab, Calgary, AB, Canada
[3] Univ Calgary, Oncol, Calgary, AB, Canada
[4] Univ Calgary, Gynecol Oncol, Calgary, AB, Canada
[5] Univ S Florida, H Lee Moffitt Canc Ctr, Anat Pathol, Tampa, FL 33682 USA
[6] Univ Calgary, Oncol Biochem & Mol Biol, Calgary, AB, Canada
关键词
D O I
10.1016/S0959-8049(16)30198-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
334
引用
收藏
页码:S65 / S65
页数:1
相关论文
共 50 条
  • [11] ERCC1 Expression Predicts Response and Survival in Locally Advanced Cervical Carcinoma Patients Treated With Concurrent Chemoradiotherapy
    Lee, H. J.
    Liang, Z. L.
    Song, E. K.
    Yun, H. J.
    Kim, S.
    Jo, D. Y.
    Kim, J. M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S540 - S540
  • [12] The Prognostic Impact of PD-L1 and CD8 Expression in Anal Cancer Patients Treated with Chemoradiotherapy
    Jiang, W. N.
    Chan, A. M. Y.
    Urgoiti, G. Roldan
    Kornaga, E.
    Mathen, P.
    Yeung, R.
    Konno, M.
    Lee, S.
    Box, A.
    Kobel, M.
    Joseph, K. J.
    Doll, C. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S62 - S63
  • [13] The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapy
    Chan, Angela M. Y.
    Urgoiti, Gloria Roldan
    Jiang, Will
    Lee, Sandra
    Kornaga, Elizabeth
    Mathen, Peter
    Yeung, Rosanna
    Enwere, Emeka K.
    Box, Alan
    Konno, Mie
    Koebel, Martin
    Joseph, Kurian
    Doll, Corinne M.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [14] Radiotherapy Scheme Effect on PD-L1 Expression for Locally Advanced Rectal Cancer
    Boustani, Jihane
    Derangere, Valentin
    Bertaut, Aurelie
    Adotevi, Olivier
    Morgand, Veronique
    Charon-Barra, Celine
    Ghiringhelli, Francois
    Mirjolet, Celine
    CELLS, 2020, 9 (09) : 1 - 20
  • [15] PD-L1 protein expression and copy number gains in HIV-positive locally advanced cervical cancer
    Loharamtaweethong, Kongsak
    Puripat, Napaporn
    Praditphol, Niphon
    Thammasiri, Jidapa
    Tangitgamol, Siriwan
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [16] PD-L1 Expression and Survival among Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy
    Sorensen, Steffen Filskov
    Zhou, Wei
    Dolled-Filhart, Marisa
    Georgsen, Jeanette Baehr
    Wang, Zhen
    Emancipator, Kenneth
    Wu, Dianna
    Busch-Sorensen, Michael
    Meldgaard, Peter
    Hager, Henrik
    TRANSLATIONAL ONCOLOGY, 2016, 9 (01): : 64 - 69
  • [17] Predicted Value of PD-L1 for Patients With Cervical Cancer Treated With Pembrolizumab
    Luo, Peng-Hui
    Mo, Dun-Chang
    Wang, Han-Lei
    Liang, Xiu-Juan
    Huang, Jian-Feng
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (13)
  • [18] Adjuvant hysterectomy in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy
    Shim, Seung-Hyuk
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (03)
  • [19] Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy
    Huang, Ta-Chen
    Liang, Cher-Wei
    Li, Yu-, I
    Guo, Jhe-Cyuan
    Lin, Chia-Chi
    Chen, Ya-Jhen
    Cheng, Ann-Lii
    Hsu, Chih-Hung
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (07) : 1803 - 1811
  • [20] Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy
    Ta-Chen Huang
    Cher-Wei Liang
    Yu-I Li
    Jhe-Cyuan Guo
    Chia-Chi Lin
    Ya-Jhen Chen
    Ann-Lii Cheng
    Chih-Hung Hsu
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 1803 - 1811